Class I/II Recall Notification Bill May Be Prelude To Broader Inquiry
This article was originally published in The Gray Sheet
Executive Summary
The Shays/Dodd pharmacy Class I/II recall notification bill may be a harbinger of a broader inquiry into the nation's device and drug recall systems by the House Government Reform and Oversight/Human Resources Subcommittee, Rep. Christopher Shays (R-Conn.) said March 11 at a press briefing in Washington, D.C.